DK447688D0 - Fremgangsmaade til isolering af basiske proteiner fra proteinblandinger - Google Patents

Fremgangsmaade til isolering af basiske proteiner fra proteinblandinger

Info

Publication number
DK447688D0
DK447688D0 DK447688A DK447688A DK447688D0 DK 447688 D0 DK447688 D0 DK 447688D0 DK 447688 A DK447688 A DK 447688A DK 447688 A DK447688 A DK 447688A DK 447688 D0 DK447688 D0 DK 447688D0
Authority
DK
Denmark
Prior art keywords
basic proteins
procedure
protein ingredients
insulating basic
insulating
Prior art date
Application number
DK447688A
Other languages
English (en)
Other versions
DK173502B1 (da
DK447688A (da
Inventor
Michael Doerschug
Rainer Obermeier
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK447688D0 publication Critical patent/DK447688D0/da
Publication of DK447688A publication Critical patent/DK447688A/da
Application granted granted Critical
Publication of DK173502B1 publication Critical patent/DK173502B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK198804476A 1987-08-11 1988-08-10 Fremgangsmåde til isolering af insulinderivater med basisk karakter fra proetinblandinger DK173502B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3726655 1987-08-11
DE19873726655 DE3726655A1 (de) 1987-08-11 1987-08-11 Verfahren zur isolierung basischer proteine aus proteingemischen, welche solche basischen proteine enthalten

Publications (3)

Publication Number Publication Date
DK447688D0 true DK447688D0 (da) 1988-08-10
DK447688A DK447688A (da) 1989-02-12
DK173502B1 DK173502B1 (da) 2001-01-08

Family

ID=6333496

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198804476A DK173502B1 (da) 1987-08-11 1988-08-10 Fremgangsmåde til isolering af insulinderivater med basisk karakter fra proetinblandinger

Country Status (19)

Country Link
US (1) US5101013A (da)
EP (1) EP0305760B1 (da)
JP (1) JP2587867B2 (da)
KR (1) KR0129539B1 (da)
AT (1) ATE96447T1 (da)
AU (1) AU609170B2 (da)
CA (1) CA1340237C (da)
DE (2) DE3726655A1 (da)
DK (1) DK173502B1 (da)
ES (1) ES2047007T3 (da)
FI (1) FI91875C (da)
HU (1) HU198218B (da)
IE (1) IE61557B1 (da)
IL (1) IL87385A (da)
NO (1) NO175004C (da)
NZ (1) NZ225746A (da)
PH (1) PH26874A (da)
PT (1) PT88230B (da)
ZA (1) ZA885871B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2097426T3 (es) * 1992-12-02 1997-04-01 Hoechst Ag Procedimiento para la obtencion de proinsulina con puentes de cistina correctamente unidos.
DK0821006T3 (da) 1996-07-26 2004-08-16 Aventis Pharma Gmbh Insulinderivater med öget zinkbinding
DE19652713C2 (de) * 1996-12-18 2001-11-22 Aventis Pharma Gmbh Verfahren zur Reinigung von Insulin und Insulinderivaten durch Chromatographie an stark saurem Kationenaustauscher
KR100341297B1 (ko) * 1997-03-29 2002-11-16 주식회사종근당 재조합활성형프로인슐린의분리.정제방법
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
US6444788B1 (en) 1999-03-15 2002-09-03 Novo Nordisk A/S Ion exchange chromatography of GLP-1, analogs and derivatives thereof
WO2000055203A1 (en) * 1999-03-15 2000-09-21 Novo Nordisk A/S Ion exchange chromatographic separation of glp-1 and related peptides
US6451987B1 (en) * 1999-03-15 2002-09-17 Novo Nordisk A/S Ion exchange chromatography of proteins and peptides
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
US7193035B2 (en) * 2002-10-29 2007-03-20 Sanofi-Aventis Deutschland Gmbh Crystals of insulin analogs and processes for their preparation
SE0300791D0 (sv) * 2003-03-20 2003-03-20 Amersham Biosciences Ab Use of ph-responsive polymers
KR20060106812A (ko) * 2003-08-21 2006-10-12 노보 노르디스크 에이/에스 라세미화 아미노산을 포함하는 폴리펩티드의 분리
EP1958879B1 (en) * 2005-08-04 2012-07-11 Toyo Seikan Kaisha, Ltd. Method for sterilization of plastic bottle
DK2349324T3 (da) 2008-10-17 2017-12-11 Sanofi Aventis Deutschland Kombination af et insulin og en glp-1-agonist
FR2947818B1 (fr) * 2009-07-09 2011-07-29 Inst Superieur Des Sciences Agronomiques Agroalimentaires Horticoles Et Du Paysage Agro Campus Ouest Utilisation d'un coproduit issu d'un procede d'extraction du lysozyme a partir de blanc d'oeuf, pour l'obtention d'au moins une proteine basique de blanc d'oeuf
KR101836070B1 (ko) 2009-11-13 2018-03-09 사노피-아벤티스 도이칠란트 게엠베하 Ｇｌｐ－１ 작용제, 인슐린 및 메티오닌을 포함하는 약제학적 조성물
JP5973918B2 (ja) 2009-11-13 2016-08-23 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Ｇｌｐ−１アゴニスト及びメチオニンを含む薬学的組成物
PT2611458T (pt) 2010-08-30 2016-12-16 Sanofi Aventis Deutschland Utilização de ave0010 para o fabrico de um medicamento para o tratamento da diabetes mellitus tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
CN108079281A (zh) 2011-08-29 2018-05-29 赛诺菲-安万特德国有限公司 用于2型糖尿病患者中的血糖控制的药物组合
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
EP2748181B1 (en) 2011-09-30 2016-03-30 GE Healthcare BioProcess R&D AB Method for purification of cleaved pro-insulin
US10421795B2 (en) * 2012-12-17 2019-09-24 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
EP3116531B1 (en) 2014-03-14 2021-10-20 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
CN107206058A (zh) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 甘精胰岛素/利西拉来固定比率配制剂
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
WO2018147393A1 (ja) * 2017-02-10 2018-08-16 三菱ケミカル株式会社 ヒトインスリン精製用分離剤及びヒトインスリンの精製方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2629568C3 (de) * 1976-07-01 1981-09-10 Hoechst Ag, 6000 Frankfurt Verfahren zur Reinigung von Insulin, seinen Analogen und Derivaten
NL7713966A (nl) * 1976-12-27 1978-06-29 Univ Minnesota Werkwijze voor het behandelen van insuline.
DK311477A (da) * 1977-07-08 1979-01-09 Leo Lab Fremgangsmaade ved fremstilling af rent insulin
US4459226A (en) * 1982-02-26 1984-07-10 Eli Lilly And Company Process for recovering insulin
DD247684A1 (de) * 1983-04-14 1987-07-15 Ulrich Krabiell Verfahren zur isolierung von insulinderivaten
ATE95236T1 (de) * 1983-04-25 1993-10-15 Chiron Corp Hybrid-dns-synthesis von reifen insulinaehnlichen wachstumsfaktoren.
DE3440988A1 (de) * 1984-11-09 1986-07-10 Hoechst Ag, 6230 Frankfurt Verfahren zur spaltung von peptiden und proteinen an der methionyl-bindung
DE3511269A1 (de) * 1985-04-12 1986-10-09 Veb Berlin-Chemie, Ddr 1199 Berlin Verfahren zur reinigung von insulin
JPS6379591A (ja) * 1986-09-22 1988-04-09 Mitsui Toatsu Chem Inc ｔＰＡの精製方法
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
EP0365858B1 (en) * 1988-10-26 1994-11-30 American Cyanamid Company Process for reducing the aggregate content of growth hormone-like materials

Also Published As

Publication number Publication date
FI91875B (fi) 1994-05-13
IE882441L (en) 1989-02-11
HU198218B (en) 1989-08-28
NZ225746A (en) 1990-11-27
NO175004B (no) 1994-05-09
DK173502B1 (da) 2001-01-08
FI883708A0 (fi) 1988-08-09
ZA885871B (en) 1989-04-26
AU609170B2 (en) 1991-04-26
DK447688A (da) 1989-02-12
NO883554L (no) 1989-02-13
IL87385A (en) 1993-08-18
JP2587867B2 (ja) 1997-03-05
FI91875C (fi) 1994-08-25
PH26874A (en) 1992-11-16
ES2047007T3 (es) 1994-02-16
IE61557B1 (en) 1994-11-16
FI883708A (fi) 1989-02-12
EP0305760A2 (de) 1989-03-08
JPS6486896A (en) 1989-03-31
HUT47958A (en) 1989-04-28
EP0305760B1 (de) 1993-10-27
CA1340237C (en) 1998-12-15
PT88230A (pt) 1989-06-30
ATE96447T1 (de) 1993-11-15
AU2059188A (en) 1989-02-16
DE3726655A1 (de) 1989-02-23
KR0129539B1 (ko) 1998-04-04
NO883554D0 (no) 1988-08-10
PT88230B (pt) 1995-03-01
DE3885214D1 (de) 1993-12-02
EP0305760A3 (en) 1990-06-06
NO175004C (no) 1994-08-17
KR890003799A (ko) 1989-04-18
US5101013A (en) 1992-03-31
IL87385A0 (en) 1989-01-31

Similar Documents

Publication Publication Date Title
DK447688D0 (da) Fremgangsmaade til isolering af basiske proteiner fra proteinblandinger
NO830110L (no) 6-substituert-s-triazolo(3,4-a)ftalazinderivater og fremgangsmaate for deres fremstilling
NO20076467L (no) Fusjonsproteiner som omfatter HIV-1 Tat- og/eller Nef-proteiner
FI844817A0 (fi) Dispergeringsmedel foer salthaltiga system.
DK1149905T3 (da) Fremgangsmåder og præparat til polypeptidteknologi
DK38189A (da) Hidtil ukendte fusionsproteiner indeholdende glutation-s-transferase
CY1112195T1 (el) Μεθοδος παρασκευης ενος πεπτιδιου με pl πανω απο 8 ή κατω απο 5
AR006188A1 (es) "composicion farmaceutica para inhibir la actividad de serinproteasa, metodo in vitro para inhibir la actividad de serinproteasa y metodo para preparar dicha composicion".
ATE393822T1 (de) Nukleinsäure bindende proteine
LV10490A (lv) DNS seciba kas kode proteinus ar HUSI-tipa inhibitoru biologisko aktivitati mineto proteinu iegusanas biotehnologiskais panemiens farmaceitiskas kompozicijas kas satur minetos proteinus
ES2170747T3 (es) Analogos superiores de trombomodulina para uso farmaceutico.
Grimbleby et al. Binding of trichloroacetic acid by protein
PT1062244E (pt) Metodos melhorados para produzir proteinas do factor viii
AMMER et al. The major protamine from stallion sperm. Isolation and amino-acid sequence
CHOLI et al. Isolation and characterization of a new ribosomal protein from the thermophilic eubacteria, Thermus thermophilus, T. aquaticus and T. flavus
DK560686D0 (da) Fremgangsmaade til fremstilling af proteiner ved hjaelp af vaertsorganismer, fortrinsvis maelkesyrebakterier
DK319384A (da) 1-0-alkyl-3-amino-propan-1,2-diol-2-0-phospholipider, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
Catalán et al. Adenosine 3′, 5′-monophosphate phosphodiesterase activity during development of the insect Ceratitis capitata
JPS5795997A (en) Removal of admixed protein from albumin-containing solution in presence of water-soluble high polymer
Bennett et al. Amino acid substitutions in mutant forms of histidinol dehydrogenase from Neurospora crassa
DK0938555T3 (da) Konstruktioner og komplekser af cyclin E
Takeshima et al. Ribosomal proteins of sea urchin eggs. I. Characterization of cytoplasmic ribosomal proteins
Cho et al. Isolation of Sunflower Seed Protein and its Chemical Composition
Vaughn et al. Phosphorylation heterogeneity of tryptic phosphopeptides of chicken riboflavin-binding protein
ES2095187A1 (es) Proteinas inactivadoras de ribosomas, denominadas alfa-ebulitina, beta-ebilitina, de la planta sambucus ubulus, l., procedimiento para su obtencion y su utilizacion.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired